CIK 0001994702 · <br>Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831365441
- Phone
- 5109252492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- FWP Offering Free Writing Prospectus
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-8 Other Securities Offered to Employees in Benefit Plans
- CERT Other Certification
- EFFECT Other Notice of Effectiveness
- 8-A12B Other Registration of Securities
Page 1 of 2 · 29 filings